Cargando…

Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN study—a randomised controlled trial

BACKGROUND: The optimal use of various therapeutic combinations for moderate/severe chronic obstructive pulmonary disease (COPD) is unclear. The GLISTEN trial compared the efficacy of two long-acting anti-muscarinic antagonists (LAMA), when combined with an inhaled corticosteroid (ICS) and a long-ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frith, Peter A, Thompson, Philip J, Ratnavadivel, Rajeev, Chang, Catherina L, Bremner, Peter, Day, Peter, Frenzel, Christina, Kurstjens, Nicol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Chronic Obstructive Pulmonary Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453631/ https://www.ncbi.nlm.nih.gov/pubmed/25841237 http://dx.doi.org/10.1136/thoraxjnl-2014-206670

Ejemplares similares

Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study
por: Buhl, Roland, et al.
Publicado: (2015)

Adherence to early pulmonary rehabilitation after COPD exacerbation and risk of hospital readmission: a secondary analysis of the COPD-EXA-REHAB study
por: Kjærgaard, Jakob, et al.
Publicado: (2020)

Physiological changes related to 10 weeks of singing for lung health in patients with COPD
por: Kaasgaard, Mette, et al.
Publicado: (2022)

Frailty in COPD: an analysis of prevalence and clinical impact using UK Biobank
por: Hanlon, Peter, et al.
Publicado: (2022)

Statins and morbidity and mortality in COPD in the COMIC study: a prospective COPD cohort study
por: Citgez, Emanuel, et al.
Publicado: (2016)

Clustering-based COPD subtypes have distinct longitudinal outcomes and multi-omics biomarkers
por: Gregory, Andrew, et al.
Publicado: (2022)

Systemic inflammation induced by exacerbation of COPD or pneumonia in patients with COPD induces cardiac troponin elevation
por: Søyseth, Vidar, et al.
Publicado: (2021)

Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD
por: Di Stefano, Antonino, et al.
Publicado: (2014)

Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial
por: Celli, Bartolome R, et al.
Publicado: (2019)

Innovating the treatment of COPD exacerbations: a phone interactive telesystem to increase COPD Action Plan adherence
por: Farias, Raquel, et al.
Publicado: (2019)

Th2 high and mast cell gene signatures are associated with corticosteroid sensitivity in COPD
por: Faiz, Alen, et al.
Publicado: (2023)

Are clinical risk scores for COPD useful?
por: Quint, Jennifer K
Publicado: (2015)

Specialist emergency care and COPD outcomes
por: Lane, Nicholas David, et al.
Publicado: (2018)

Airway gene expression in COPD is dynamic with inhaled corticosteroid treatment and reflects biological pathways associated with disease activity
por: van den Berge, Maarten, et al.
Publicado: (2014)

BEAM study (Breathing, Education, Awareness, Movement): a randomised controlled feasibility trial of tai chi exercise in patients with COPD
por: Yeh, Gloria Y., et al.
Publicado: (2020)

Increased expression of placenta growth factor in COPD
por: Cheng, S-L, et al.
Publicado: (2008)

COPD-Lower Respiratory Tract Infection Visual Analogue Score (c-LRTI-VAS) validation in stable and exacerbated patients with COPD
por: Prins, Hendrik Johannes, et al.
Publicado: (2021)

Automatic oxygen titration versus constant oxygen flow rates during walking in COPD: a randomised controlled, double-blind, crossover trial
por: Schneeberger, Tessa, et al.
Publicado: (2023)

Angiopoietin-like protein 4 and cardiovascular function in COPD
por: Waschki, B, et al.
Publicado: (2016)

Breathing–swallowing discoordination is associated with frequent exacerbations of COPD
por: Nagami, Shinsuke, et al.
Publicado: (2017)

Frequency and severity of respiratory infections prior to COPD diagnosis and risk of subsequent postdiagnosis COPD exacerbations and mortality: EXACOS-UK health care data study
por: Whittaker, Hannah, et al.
Publicado: (2023)

Identifying the challenges and facilitators of implementing a COPD care bundle
por: Lennox, Laura, et al.
Publicado: (2014)

Predictive value of prebronchodilator and postbronchodilator spirometry for COPD features and outcomes
por: Fortis, Spyridon, et al.
Publicado: (2017)

No association between DNA methylation and COPD in never and current smokers
por: de Vries, Maaike, et al.
Publicado: (2018)

Reducing hospital admissions for COPD: perspectives following the Christchurch Earthquake
por: Epton, Michael, et al.
Publicado: (2018)

ACE and response to pulmonary rehabilitation in COPD: two observational studies
por: Kon, Samantha S C, et al.
Publicado: (2017)

Stability in eosinophil categorisation during subsequent severe exacerbations of COPD
por: Citgez, Emanuel, et al.
Publicado: (2021)

Physical and affective components of dyspnoea are improved by pulmonary rehabilitation in COPD
por: Grosbois, Jean-Marie, et al.
Publicado: (2022)

Evaluation of the Norwegian version of the Dyspnoea-12 questionnaire in patients with COPD
por: Garratt, Andrew Malcolm, et al.
Publicado: (2022)

Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial
por: Brill, Simon E, et al.
Publicado: (2015)

COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia: nationwide data on 67 000 patients with COPD followed for 12 months
por: Sivapalan, Pradeesh, et al.
Publicado: (2019)

Determinants and outcomes of physical activity in patients with COPD: a systematic review
por: Gimeno-Santos, Elena, et al.
Publicado: (2014)

Increased skeletal muscle-specific microRNA in the blood of patients with COPD
por: Donaldson, Anna, et al.
Publicado: (2013)

Targeted lung denervation for moderate to severe COPD: a pilot study
por: Slebos, Dirk-Jan, et al.
Publicado: (2015)

Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD
por: Echevarria, C, et al.
Publicado: (2016)

Longitudinal change in quality of life following hospitalisation for acute exacerbations of COPD
por: Steer, John, et al.
Publicado: (2015)

An evaluation of factors associated with completion and benefit from pulmonary rehabilitation in COPD
por: Boutou, Afroditi K, et al.
Publicado: (2014)

Patients’ practices and experiences of using nebuliser therapy in the management of COPD at home
por: Alhaddad, B, et al.
Publicado: (2015)

Physical frailty and pulmonary rehabilitation in COPD: a prospective cohort study
por: Maddocks, Matthew, et al.
Publicado: (2016)

Airway responsiveness to methacholine and incidence of COPD: an international prospective cohort study
por: Marcon, Alessandro, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tc2oam8vt341fh2dadkfmsa0r1